US EditionPublished • loading... • Updated
Retaturnida Brings Unexpected Changes in the Fight Against Obesity
Summary by financiarul.ro
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
A advanced clinical study shows that retatriated, Eli Lilly's new medicine, determines an average decrease of 28.7% of pregnancy, over existing treatments, and brings additional benefits for articular pain and cardiovascular health. The treatment market for obesity is constantly growing, and pharmaceutical companies are looking for more effective solutions. In this context, retatriated, a new drug developed [...]
·Romania
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
